Santen Pharmaceutical Co Ltd (SNPHY)
10.27
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Santen Pharmaceutical Price to Book Value: 1.844 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 1.844 |
| May 16, 2024 | 1.844 |
| May 15, 2024 | 1.829 |
| May 14, 2024 | 1.840 |
| May 13, 2024 | 1.934 |
| May 10, 2024 | 1.934 |
| May 09, 2024 | 1.853 |
| May 08, 2024 | 1.781 |
| May 07, 2024 | 1.759 |
| May 06, 2024 | 1.782 |
| May 03, 2024 | 1.794 |
| May 02, 2024 | 1.788 |
| May 01, 2024 | 1.785 |
| April 30, 2024 | 1.785 |
| April 29, 2024 | 1.739 |
| April 26, 2024 | 1.687 |
| April 25, 2024 | 1.717 |
| April 24, 2024 | 1.739 |
| April 23, 2024 | 1.732 |
| April 22, 2024 | 1.708 |
| April 19, 2024 | 1.690 |
| April 18, 2024 | 1.658 |
| April 17, 2024 | 1.694 |
| April 16, 2024 | 1.644 |
| April 15, 2024 | 1.638 |
| Date | Value |
|---|---|
| April 12, 2024 | 1.690 |
| April 11, 2024 | 1.690 |
| April 10, 2024 | 1.696 |
| April 09, 2024 | 1.696 |
| April 08, 2024 | 1.672 |
| April 05, 2024 | 1.758 |
| April 04, 2024 | 1.711 |
| April 03, 2024 | 1.696 |
| April 02, 2024 | 1.654 |
| April 01, 2024 | 1.682 |
| March 31, 2024 | |
| March 28, 2024 | 1.672 |
| March 27, 2024 | 1.672 |
| March 26, 2024 | 1.672 |
| March 25, 2024 | 1.66 |
| March 22, 2024 | 1.648 |
| March 21, 2024 | 1.648 |
| March 20, 2024 | 1.648 |
| March 19, 2024 | 1.658 |
| March 18, 2024 | 1.66 |
| March 15, 2024 | 1.685 |
| March 14, 2024 | 1.663 |
| March 13, 2024 | 1.663 |
| March 12, 2024 | 1.670 |
| March 11, 2024 | 1.687 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.022
Minimum
Sep 27 2022
2.920
Maximum
Sep 29 2020
1.904
Average
1.833
Median
Oct 12 2021
Price to Book Value Benchmarks
| Takeda Pharmaceutical Co Ltd | 0.8695 |
| Nxera Pharma Co Ltd | 1.998 |
| PeptiDream Inc | 5.887 |
| Healios KK | 3.558 |
| AnGes Inc | 0.4409 |
Price to Book Value Related Metrics
| PE Ratio | 19.95 |
| PS Ratio | 1.786 |
| Price to Free Cash Flow | 8.698 |
| Price | 10.27 |
| Earnings Yield | 5.01% |
| Market Cap | 3.729B |
| Operating PE Ratio | 13.87 |
| Normalized PE Ratio | 19.95 |